Big Rock Partners Acquisition (Warrant)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BRPAW and buy or sell other stocks, ETFs, and their options commission-free!About BRPAW
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.
CEOJonathan C. Javitt, MD
CEOJonathan C. Javitt, MD
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
BRPAW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume15.37K
Average volume15.37K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.50
52 Week high$0.50
52 Week low$0.042
52 Week low$0.042
Stock Snapshot
As of today, Big Rock Partners Acquisition (Warrant)(BRPAW) shares are valued at $0.10.
On 2025-12-19, Big Rock Partners Acquisition (Warrant)(BRPAW) stock opened at —, reached a high of —, and a low of —.
The Big Rock Partners Acquisition (Warrant)(BRPAW)'s current trading volume is 0, compared to an average daily volume of 15.37K.
In the last year, Big Rock Partners Acquisition (Warrant)(BRPAW) shares hit a 52-week high of $0.50 and a 52-week low of $0.04.
In the last year, Big Rock Partners Acquisition (Warrant)(BRPAW) shares hit a 52-week high of $0.50 and a 52-week low of $0.04.